ChemoCentryx
CCXI
#3202
Rank
โ‚ฌ3.54 B
Marketcap
49,23ย โ‚ฌ
Share price
0.00%
Change (1 day)
35.52%
Change (1 year)

Revenue for ChemoCentryx (CCXI)

Revenue in 2022 (TTM): โ‚ฌ33.41 Million

According to ChemoCentryx's latest financial reports the company's current revenue (TTM ) is โ‚ฌ35.22 Million. In 2021 the company made a revenue of โ‚ฌ28.16 Million a decrease over the revenue in the year 2020 that were of โ‚ฌ52.35 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for ChemoCentryx from 2011 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) โ‚ฌ33.41 M18.64%
2021 โ‚ฌ28.16 M-46.2%
2020 โ‚ฌ52.35 M63.12%
2019 โ‚ฌ32.09 M-14.37%
2018 โ‚ฌ37.47 M-45.49%
2017 โ‚ฌ68.75 M532.45%
2016 โ‚ฌ10.87 M
2015 N/A
2014 N/A-100%
2013 โ‚ฌ4.38 M7.11%
2012 โ‚ฌ4.09 M-83.2%
2011 โ‚ฌ24.38 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
โ‚ฌ9.15 B 25,900.00%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.08 B 147,749.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ38.11 B 108,106.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚ฌ44.92 B 127,413.44%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ83.04 B 235,641.94%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ30.80 B 87,356.99%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ52.69 B 149,475.27%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚ฌ15.42 B 43,690.32%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
โ‚ฌ59.16 B 167,854.30%๐Ÿ‡บ๐Ÿ‡ธ USA